Skip to main content

Immix Biopharma, Inc.

IMMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001873835

No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Immix Biopharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Immix Biopharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Immix Biopharma, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Chang Nancy TDirector428,190May 29, 20262
Buchan Melissa JaneDirector28,705May 29, 20261
Adams Helen C.Director181,004May 29, 20261
Marquet MagdaDirector52,342May 29, 20261
Rachman Ilya MCEO and Chairman1,141,683May 29, 20262
Ng CareyDirector26,250May 29, 20261
Morris Gabriel SCFO, President291,429May 29, 20262
Hsu JasonDirector899,250May 29, 20261
Chudnovsky YekaterinaDirector6,250May 29, 20261
Senn SeanOther: Under 10% owner899,800Jul 22, 20220
Torchilin Vladimir PScientific Co-Founder905,200Dec 20, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 10, 2025 (view filing)Dec 10Same dayRachman Ilya MCEO and ChairmanPPurchase+746$6.67+$4.98K+0.1%1.14M after
Dec 10, 2025 (view filing)Dec 10Same dayMorris Gabriel SCFOPPurchase+770$6.58+$5.07K+0.3%291.4K after
Sep 17, 2025 (view filing)Sep 17Same dayRachman Ilya MCEO and ChairmanPPurchase+2.50K$2.02+$5.05K+0.2%1.14M after
Sep 17, 2025 (view filing)Sep 161 dayMorris Gabriel SCFOPPurchase+2.60K$1.97+$5.12K+0.9%290.7K after
Jun 20, 2025 (view filing)Jun 182 daysRachman Ilya MCEO and ChairmanPPurchase+2.18K$2.30+$5.01K+0.2%1.14M after
Jun 20, 2025 (view filing)Jun 182 daysMorris Gabriel SCFOPPurchase+2.23K$2.28+$5.07K+0.8%288.1K after
Dec 26, 2024 (view filing)Dec 20-236 daysHsu JasonDirectorPPurchase+47.7K$2.19+$104.3K+5.6%893.0K after2 lots
Aug 26, 2024 (view filing)Aug 21-225 daysLateHsu JasonDirectorPPurchase+23.1K$2.24+$51.7K+2.8%845.3K after2 lots
Aug 19, 2024 (view filing)Aug 163 daysNg CareyDirectorPPurchase+10.0K$1.86+$18.6K+100.0%20.0K after
Jul 31, 2024 (view filing)Jul 18-2413 daysLateHsu JasonDirectorPPurchase+9.20K$2.12+$19.5K+1.1%822.2K after2 lots
Jun 10, 2024 (view filing)Jun 73 daysMorris Gabriel SCFOPPurchase+2.50K$2.12+$5.30K+0.9%285.8K after
Jun 10, 2024 (view filing)Jun 73 daysRachman Ilya MCEO and ChairmanPPurchase+2.60K$2.13+$5.54K+0.2%1.14M after
Jun 5, 2024 (view filing)Jun 41 dayMorris Gabriel SCFOPPurchase+3.30K$1.81+$5.97K+1.2%283.3K after
Jun 5, 2024 (view filing)Jun 41 dayRachman Ilya MCEO and ChairmanPPurchase+3.30K$1.81+$5.97K+0.3%1.13M after
May 14, 2024 (view filing)May 14Same dayMorris Gabriel SCFOPPurchase+4.50K$2.23+$10.0K+5.5%85.8K after
May 14, 2024 (view filing)May 14Same dayRachman Ilya MCEO and ChairmanPPurchase+4.30K$2.25+$9.68K+0.5%912.0K after
Dec 12, 2023 (view filing)Dec 8-114 daysHsu JasonDirectorPPurchase+56.0K$4.76+$266.8K+7.4%813.0K after2 lots
Sep 18, 2023 (view filing)Sep 11-157 daysLateHsu JasonDirectorPPurchase+72.0K$2.78+$200.4K+10.5%757.0K after4 lots
Sep 15, 2023 (view filing)Sep 141 dayNg CareyDirectorPPurchase+10.0K$2.58+$25.8KNew position10.0K after
Sep 14, 2023 (view filing)Sep 122 daysAdams Helen C.DirectorPPurchase+13.0K$2.96+$38.5KNew position13.0K after
Sep 12, 2023 (view filing)Sep 84 daysHsu JasonDirectorPPurchase+10.0K$2.53+$25.3K+1.5%685.0K after
Sep 11, 2023 (view filing)Sep 74 daysBuchan Melissa JaneDirectorPPurchase+20.0K$2.46+$49.2KNew position20.0K after
Sep 8, 2023 (view filing)Sep 62 daysMarquet MagdaDirectorPPurchase+9.00K$2.47+$22.2K+81.8%20.0K after
Sep 6, 2023 (view filing)Sep 51 dayMarquet MagdaDirectorPPurchase+10.0K$2.47+$24.7K+1,000.0%11.0K after
Sep 5, 2023 (view filing)Aug 315 daysMarquet MagdaDirectorPPurchase+1.00K$2.01+$2.01KNew position1.00K after
Nov 15, 2022 (view filing)Nov 141 dayRachman Ilya MCEO and ChairmanPPurchase+5.20K$1.01+$5.23K+0.6%907.7K after3 lots
Nov 15, 2022 (view filing)Nov 141 dayMorris Gabriel SCFOPPurchase+5.20K$0.94+$4.89K+6.8%81.3K after
Jul 22, 2022 (view filing)Jul 148 daysSenn SeanOther: Under 10% ownerSSale−200$2.75−$5500.0%899.8K afterAmended
Dec 20, 2021 (view filing)4:15 PM ETDec 20Same dayMorris Gabriel SChief Financial OfficerPPurchase+2.00K$5.00+$10.0K+2.7%76.1K after
Dec 20, 2021 (view filing)Dec 20Same dayHsu JasonDirectorPPurchase+50.0K$5.00+$250.0KNew position50.0K after
Dec 20, 2021 (view filing)Dec 20Same dayRachman Ilya MCEO and ChairmanPPurchase+2.50K$5.00+$12.5K+0.3%902.5K after
Dec 20, 2021 (view filing)Dec 17-203 daysTorchilin Vladimir PScientific Co-FounderPPurchase+5.20K$4.78+$24.8K+0.6%905.2K after2 lots
Dec 20, 2021 (view filing)Dec 20Same dayNg CareyDirectorPPurchase+25.0K$5.00+$125.0K+2.5%1.03M after